Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.13% | 59.47% | 8.98% | -72.85% | -1.51% |
| Total Depreciation and Amortization | 0.13% | 238.13% | 8.97% | -69.77% | -1.50% |
| Total Amortization of Deferred Charges | 0.13% | -72.99% | 8.99% | 250.27% | -1.60% |
| Total Other Non-Cash Items | 0.14% | -64.66% | 8.98% | 283.61% | 1.51% |
| Change in Net Operating Assets | 0.13% | 1,658.61% | -8.98% | -559.31% | -1.44% |
| Cash from Operations | 0.13% | 74.58% | 8.98% | -60.10% | -1.51% |
| Capital Expenditure | -0.13% | -638.44% | -9.02% | 74.78% | 1.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.21% | -65.07% | -9.09% | -213.33% | 1.79% |
| Cash from Investing | -0.13% | -509.84% | -8.94% | 68.20% | 1.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -63.51% | 0.00% | 244.90% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 52.33% | 0.00% | -8,762.13% | 0.00% |
| Cash from Financing | -0.13% | 50.44% | -8.98% | -64,284.00% | 1.57% |
| Foreign Exchange rate Adjustments | 0.00% | -40.30% | -9.84% | 81.85% | 1.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.13% | 274.21% | 8.98% | -85.53% | -1.51% |